Three Year Update of the Phase II ABT-199 (Venetoclax) and Ibrutinib in Mantle Cell Lymphoma (AIM) Study

Sasanka M Handunnetti, Mary Ann Anderson, Kate Burbury, Rodney J Hicks, Besiat Birbirsa, Mathias Bressel, Juliana Di Iulio, David Alan Westerman, Stephen Lade, Rishu Agarwal, Mark A Dawson, Sarah-Jane Dawson, Rachel Koldej, David Ritchie, John F Seymour, Andrew W Roberts, Constantine S Tam